Wave Life Sciences Third Quarter 2024 Financial Results Scheduled for November 12, 2024
Wave Life Sciences (Nasdaq: WVE) has announced it will host a live webcast and conference call on Tuesday, November 12, 2024, at 8:30 a.m. ET to discuss its third quarter 2024 financial results and provide business updates. The event will be accessible through the company's investor relations website, with analysts able to participate in the Q&A session through a provided audio conferencing link. An archived version of the webcast will be available on the company's website following the live event.
Wave Life Sciences (Nasdaq: WVE) ha annunciato che ospiterà un webcast dal vivo e una telefonata di conferenza martedì 12 novembre 2024, alle 8:30 ET, per discutere i suoi risultati finanziari del terzo trimestre 2024 e fornire aggiornamenti aziendali. L'evento sarà accessibile tramite il sito web delle relazioni con gli investitori della società, con gli analisti che potranno partecipare alla sessione di Q&A tramite un link di conferenza audio fornito. Una versione archiviata del webcast sarà disponibile sul sito web della società dopo l'evento dal vivo.
Wave Life Sciences (Nasdaq: WVE) ha anunciado que llevará a cabo un webcast en vivo y una llamada de conferencia el martes 12 de noviembre de 2024 a las 8:30 a.m. ET para discutir sus resultados financieros del tercer trimestre de 2024 y proporcionar actualizaciones comerciales. El evento será accesible a través del sitio web de relaciones con inversores de la compañía, y los analistas podrán participar en la sesión de preguntas y respuestas a través de un enlace de conferencia de audio proporcionado. Una versión archivada del webcast estará disponible en el sitio web de la compañía después del evento en vivo.
웨이브 라이프 사이언스(Wave Life Sciences)(Nasdaq: WVE)는 2024년 11월 12일 화요일 오전 8시 30분 ET에 라이브 웹캐스트 및 전화 회의를 진행하여 2024년 3분기 재무 결과를 논의하고 사업 업데이트를 제공할 것이라고 발표했습니다. 이 행사는 회사의 투자자 관계 웹사이트를 통해 접근 가능하며, 분석가들은 제공된 오디오 회의 링크를 통해 Q&A 세션에 참여할 수 있습니다. 라이브 이벤트 후 회사 웹사이트에서 웹캐스트의 아카이브 버전을 볼 수 있습니다.
Wave Life Sciences (Nasdaq: WVE) a annoncé qu'il organisera un webinaire en direct et une conférence téléphonique le mardi 12 novembre 2024 à 8h30 ET pour discuter de ses résultats financiers du troisième trimestre 2024 et fournir des mises à jour commerciales. L'événement sera accessible via le site Web des relations avec les investisseurs de l'entreprise, et les analystes pourront participer à la session de questions-réponses via un lien de conférence audio fourni. Une version archivée du webinaire sera disponible sur le site Web de l'entreprise après l'événement en direct.
Wave Life Sciences (Nasdaq: WVE) hat angekündigt, dass am Dienstag, den 12. November 2024, um 8:30 Uhr ET ein Live-Webcast und eine Telefonkonferenz stattfinden werden, um die Finanzergebnisse des dritten Quartals 2024 zu besprechen und Unternehmensupdates bereitzustellen. Die Veranstaltung wird über die Investor-Relations-Website des Unternehmens zugänglich sein, und Analysten können über einen bereitgestellten Audio-Konferenzlink an der Q&A-Session teilnehmen. Eine archivierte Version des Webcasts wird nach der Live-Veranstaltung auf der Website des Unternehmens verfügbar sein.
- None.
- None.
CAMBRIDGE, Mass., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, will host a live webcast and conference call at 8:30 a.m. ET on Tuesday, November 12, 2024, to review the company’s third quarter 2024 financial results and provide business updates.
The webcast and conference call may be accessed by visiting “Investor Events” on the investors section of the Wave Life Sciences website: https://ir.wavelifesciences.com/events-publications/events.
Analysts planning to participate during the Q&A portion of the live call can join the conference call at the following audio conferencing link: available here. Once registered, participants will receive the dial-in information.
Following the live event, an archived version of the webcast will be available on the Wave Life Sciences website.
About Wave Life Sciences
Wave Life Sciences (Nasdaq: WVE) is a biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health. Wave’s RNA medicines platform, PRISM®, combines multiple modalities, chemistry innovation and deep insights in human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes editing, splicing, RNA interference and antisense silencing, providing Wave with unmatched capabilities for designing and sustainably delivering candidates that optimally address disease biology. Wave’s diversified pipeline includes clinical programs in Duchenne muscular dystrophy, Alpha-1 antitrypsin deficiency and Huntington’s disease, as well as a preclinical program in obesity. Driven by the calling to “Reimagine Possible”, Wave is leading the charge toward a world in which human potential is no longer hindered by the burden of disease. Wave is headquartered in Cambridge, MA. For more information on Wave’s science, pipeline and people, please visit www.wavelifesciences.com and follow Wave on X (formerly Twitter) and LinkedIn.
Investor Contact:
Kate Rausch
+1 617-949-4827
krausch@wavelifesci.com
Media Contact:
Alicia Suter
+1 617-949-4817
asuter@wavelifesci.com
FAQ
When will Wave Life Sciences (WVE) release Q3 2024 earnings?
How can investors access Wave Life Sciences (WVE) Q3 2024 earnings call?
Will Wave Life Sciences (WVE) Q3 2024 earnings call be recorded?
